Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions
Infections, Pediatrics
Interventions
DRUG

Ceftaroline fosamil

"Subjects ≥ 6 months old: 12 mg/kg IV for subjects weighing ≤ 33 kg and 400 mg for subjects weighing \> 33 kg will be infused over 60 (± 10) minutes every 8 hours (q8h) (± 1 hour)~Subjects \< 6 months old: 8mg/kg infused over 60 (± 10) minutes every 8 hours (q8h) (± 1 hour)"

DRUG

Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam

"Vancomycin 15mg/kg IV over 60 minutes (or a maximum of 10mg/min whichever is longer) +/- Aztreonam 30 mg/kg IV every 8 hours over 60 minutes (for infections involving gram negative pathogen suspected or confirmed)~Cefazolin 75mg/kg IV divided every 8 hours over 60 minutes (for sites that do not empirically cover for MRSA) +/- Aztreonam 30 mg/kg IV every 8 hours over 60 minutes (for infections involving gram negative pathogen suspected or confirmed"

DRUG

Cephalexin or Clindamycin or Linezolid

"Possible oral switch on or after study day 4.~Cephalexin: 25 mg/kg q6h PO or Clindamycin: 10 mg/kg q8h PO or Linezolid 600mg q12h (cohort 1) or 10 mg/kg q8h (cohorts 2,3 and 4) PO."

Trial Locations (71)

Unknown

Investigational Site - Phoenix, Phoenix

Investigational Site - Orange, Orange

Investigational Site - San Diego, San Diego

Investigational Site - Jacksonville, Jacksonville

Investigational Site - Atlanta, Atlanta

Investigational Site - Chicago 1, Chicago

Investigational Site - Chicago 2, Chicago

Investigational Site - Springfield, Springfield

Investigational Site - Shreveport, Shreveport

Investigational Site - Baltimore, Baltimore

Investigational Site - Detroit, Detroit

Investigational Site - Brooklyn, Brooklyn

Investigational Site - New Hyde Park, New Hyde Park

Investigational Site - Rochester, Rochester

Investigational Site - Bronx, The Bronx

Investigational Site - Akron, Akron

Investigational Site - Cleveland 1, Cleveland

Investigational Site - Cleveland 2, Cleveland

Investigational Site - Toledo, Toledo

Investigational Site - Pittsburgh, Pittsburgh

Investigational Site - Charleston, Charleston

Investigational Site - Memphis, Memphis

Investigational Site - Austin 1, Austin

Investigational Site - Fort Worth, Fort Worth

Investigational Site - Norfolk, Norfolk

Investigational Site - Richmond, Richmond

Investigational Site - Seattle, Seattle

Investigational Site - Morgantown, Morgantown

Investigational Site - Buenos Aires 1, Buenos Aires

Investigational Site - Buenos Aires 2, Buenos Aires

Investigational Site - Buenos Aires 3, Buenos Aires

Investigational Site - Buenos Aires 4, Buenos Aires

Investigational Site - Buenos Aires 5, Buenos Aires

Investigational Site - Buenos Aires 6, Buenos Aires

Investigational Site - Santa Fe 1, Santa Fe

Investigational Site - Santa Fe 2, Santa Fe

Investigational Site - Puente Alto, Puente Alto

Investigational Site - San Ramon, San Ramón

Investigational Site - Vitacura, Vitacura

Investigational Site - Vina Del Mar, Viña del Mar

Investigational Site - Tbilisi 1, Tbilisi

Investigational Site - Tbilisi 2, Tbilisi

Investigational Site - Daugavpils, Daugavpils

Investigational Site - Liepaja, Liepāja

Investigational Site - Rezekne, Rēzekne

Investigational Site - Riga, Riga

Investigational Site - Kaunas, Kaunas

Investigational Site - Vilnius, Vilnius

Investigational Site - Bydgoszcz 1, Bydgoszcz

Investigational Site - Bydgoszcz 2, Bydgoszcz

Investigational Site - Lodz, Lodz

Investigational Site - Lublin, Lublin

Investigational Site - Rzeszow, Rzeszów

Investigational Site - Warszawa, Warsaw

Investigational Site - Bucharest 1, Bucharest

Investigational Site - Bucharest 2, Bucharest

Investigational Site - Constanta, Constanța

Investigational Site - Tirgu Mures, Târgu Mureş

Investigational Site - Timisoara, Timișoara

Investigational Site - Cape Town 1, Cape Town

Investigational Site - Cape Town 2, Cape Town

Investigational Site - Cape Town 3, Cape Town

Investigational Site - Johannesburg, Johannesburg

Investigational Site - Badalona, Badalona

Investigational Site - Esplugues de Llobregat, Esplugues de Llobregat

Investigational Site - Getafe, Getafe

Investigational Site - Madrid 1, Madrid

Investigational Site - Madrid 2, Madrid

Investigational Site - Madrid 3, Madrid

Investigational Site - Santiago de Compostela, Santiago de Compostela

Investigational Site - Valencia, Valencia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Forest Laboratories

INDUSTRY

NCT01400867 - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections | Biotech Hunter | Biotech Hunter